Cost-effectiveness of Statin Use Guidelines

JAMA Cardiol. 2021 Mar 1;6(3):363-364. doi: 10.1001/jamacardio.2020.6121.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cholesterol, LDL
  • Cost-Benefit Analysis
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Quality-Adjusted Life Years

Substances

  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors